BBNX
BBNX
NASDAQ · Health Care

Beta Bionics Inc

$11.31
+0.07 (+0.62%)
As of Mar 25, 10:04 PM ET ·
Financial Highlights (FY 2026)
Revenue
109.78M
Net Income
-80,158,594
Gross Margin
55.4%
Profit Margin
-73.0%
Rev Growth
+724.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 55.4% 50.2% 50.2% 50.2%
Operating Margin -71.5% 19.0% 21.4% 17.5%
Profit Margin -73.0% 12.9% 12.6% 15.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 109.78M 236.47M 231.04M 255.29M
Gross Profit 60.82M 118.62M 115.90M 128.06M
Operating Income -78,495,329 44.94M 49.50M 44.76M
Net Income -80,158,594 30.56M 29.00M 38.71M
Gross Margin 55.4% 50.2% 50.2% 50.2%
Operating Margin -71.5% 19.0% 21.4% 17.5%
Profit Margin -73.0% 12.9% 12.6% 15.2%
Rev Growth +724.3% +7.0% -7.5% +15.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 159.86M 166.94M 156.08M
Total Equity 327.82M 355.88M 355.93M
D/E Ratio 0.49 0.47 0.44
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -90,406,432 76.07M 67.45M 82.18M
Free Cash Flow 21.68M 20.54M 23.28M